Clinical Trials Directory

Trials / Unknown

UnknownNCT05191433

Effects of Mechanical Ventilation on the Diaphragm in COVID-19 Intensive Care Patients. A Post-mortem Pathology Study

Effects of Mechanical Ventilation on the Diaphragm in COVID-19 Intensive Care Patients. A Post-mortem Pathology Study.

Status
Unknown
Phase
Study type
Observational
Enrollment
41 (estimated)
Sponsor
Azienda Sanitaria-Universitaria Integrata di Udine · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The diaphragm is the fundamental muscle of the respiratory system. The diaphragmatic dysfunction is present in 60% of critical patients at hospital admission and up to 80% after prolonged mechanical ventilation and difficult weaning. Risk factors associated with diaphragm dysfunction and atrophy are sepsis, trauma, sedatives, steroids, and muscle relaxants. The main pathology characteristics of diaphragm biopsies of mechanically ventilated patients are atrophy and a reduction in contractility, determining an impact on the clinical outcome. Shi et al. found a higher section area of the diaphragm muscle fiber in biopsies of post mortem COVID-19 patients versus negative patients, independently from days of mechanical ventilation. The hypothesis of our study is to identify different clusters of pathological presentation in post-mortem COVID-19 mechanically ventilated patients.

Conditions

Timeline

Start date
2020-11-01
Primary completion
2021-03-31
Completion
2022-01-20
First posted
2022-01-13
Last updated
2022-01-13

Locations

2 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT05191433. Inclusion in this directory is not an endorsement.

Effects of Mechanical Ventilation on the Diaphragm in COVID-19 Intensive Care Patients. A Post-mortem Pathology Study (NCT05191433) · Clinical Trials Directory